Clinical Roundup Datopotamab deruxtecan did not reach statistical significance for OS in metastatic or advanced nonsquamous NSCLC in phase III trial May 31, 2024Vol.50 No.22
Clinical Roundup ACCC and LUNGevity launch virtual roadmap to support EHR integration for biomarker testing May 31, 2024Vol.50 No.22
Clinical Roundup Cyclophosphamide may expand transplant donor pool for patients with blood cancers May 24, 2024Vol.50 No.21
Clinical Roundup Orserdu combinations show favorable safety profiles for ER+, HER2- metastatic breast cancer in phase Ib/II trials May 24, 2024Vol.50 No.21
Clinical Roundup Vepdegestrant + Ibrance continue to show clinical benefit for ER+/HER2- breast cancer in phase Ib trial May 24, 2024Vol.50 No.21
Clinical Roundup NCCN publishes patient resource for small bowel adenocarcinoma May 24, 2024Vol.50 No.21
Clinical Roundup NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland May 24, 2024Vol.50 No.21
